FormWeb • Do Not Crush

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

SDS Online Do Not Crush OHS Pharmacy Contact Louisiana Poison Control
(800) 222-1222

Webpage Links

Add Formweb to your mobile device

Android iOS

Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.

Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.

Ochsner Health

Ochsner Health System Formulary

Formulary Addition Request Questions or Suggestions?

Do Not Crush

Please review each of these drugs carefully.

acetaminophen	Tablet Extended release
acetaminophen-oxycodone	Tablet Extended release; tablet disruption may cause a potentially fatal overdose
albuterol	Tablet Extended release
alendronate	Tablet Mucous membrane irritant Tablet Effervescent tablet
alfuzosin	Tablet Extended release
ALPRAZolam	Tablet Extended release
ambrisentan	Tablet Film-coated; hazardous substance
amoxicillin-clavulanate	Tablet Extended release
aspirin	Capsule, tablet Delayed release; enteric-coated
aspirin-dipyridamole	Capsule Extended release. Capsule may be opened; contents include an aspirin tablet that maybe chewed and dipyridamole pellets that may be sprinkled on applesauce.
atomoxetine	Capsule contents can cause ocular irritation.
benzonatate	Capsule Swallow whole; pharmacologic action may cause choking if chewed or opened and swallowed.
bisacodyl	Tablet, Enteric coated Capsule - Liquid filled
bosentan	Tablet: Teratogenic potential; hazardous substance; women who are or may be pregnant should not handle crushed or broken tablets
budesonide	Tablet Extended release; coating on tablet designed to break down at pH of ≥7 Capsule Extended release Capsule Delayed release
buPROPion	Tablet Manufacturer recommendation Tablet Extended release Tablet Slow release
carBAMazepine	Tablet Extended release Capsule Extended release
carbidopa-levodopa	Capsule Extended release Tablet Extended release
carbidopa/entacapone/levodopa	Tablet: Manufacturer recommendation; combining multiple tablets or portions of tablets may lead to an overdose of entacapone
carvedilol	Capsule Extended release; may add contents to chilled applesauce and consume immediately.
cefaclor	Tablet Extended release
cefuroxime	Tablet - Note: Taste / use suspension for children
chlorpheniramine	Tablet Extended release
cinacalcet	Tablets are not scored and cutting may cause inaccurate dosage
clarithromycin	Tablet Extended release
cloNIDine	Tablet Extended release
colestipol	Tablet Slow release
cyclobenzaprine	Capsule Extended release
cyclophosphamide	Capsule, tablet Hazardous substance; manufacturer recommendation
dabigatran	Capsule Bioavailability increases by 75% when the pellets are taken without the capsule shell
darifenacin	Tablet Slow Release
dasatinib	Tablet Film-coated. Manufacturer recommendation; active ingredients are surrounded by a wax matrix to prevent health care exposure. Caregivers who are or could become pregnant should not handle crushed or broken tablets; hazardous substance.
deferasirox	Tablet Do not chew or swallow whole; do not give as tablets meant to be given as a liquid
desvenlafaxine	Tablet Extended release
dexlansoprazole	Capsule Delayed release
diclofenac	Tablet Extended release
diclofenac-misoprostol	Tablet Delayed release; enteric coated
didanosine	Capsule Delayed release
dilTIAZem	Capsule Extended release Tablet Extended release
disopyramide	Capsule Extended release; form within a special capsule
divalproex sodium	Tablet Delayed release; hazardous substance Tablet Extended release; hazardous substance Capsule Delayed release; hazardous substance
docusate	Capsule: Taste
donepezil	Tablet Film-coated; chewing or crushing may increase rate of absorption
doxazosin	Tablet Extended release
doxycycline	Tablet Delayed release; tablet may be crushed without damaging or crushing delayed-release pellets Tablet Delayed release Capsule Delayed release Tablet Film-coated. Tablet is scored and may be split; 150 mg tablets can be broken into two-thirds or one-third to provide a 100 mg and 50 mg strength, respectively
DULoxetine	Capsule Delayed release ; may add contents to apple juice or applesauce but not chocolate
dutasteride	Capsule Mucus membrane irritation; capsule should not be handled by pregnant women dueto teratogenic potential; hazardous substance
ergocalciferol	Capsule Liquid filled
erythromycin	Tablet, Enteric-coated Tablet Delayed release; enteric-coated Capsule Enteric-coated pellets
esomeprazole	Capsule Delayed release
etravirine	Tablet Pharmacokinetic amorphous solid dispersion technology may be affected. Tablet should be swallowed whole and not crushed; tablet may be dispersed in water.
everolimus	Tablet Manufacturer recommendation; mucous membrane irritant; hazardous substance; pharmacokinetic amorphous solid dispersion technology may be affected
fenofibrate	Tablet Film-coated; manufacturer recommendation Capsule Extended release
fenofibric acid	Tablet Manufacturer recommendation
ferrous sulfate	Tablet Delayed release Tablet Extended release, manufacturer recommendation
fesoterodine	Tablet Extended release
fexofenadine	Tablet Extended release
finasteride	Women who are, or may become, pregnant should not handle crushed or broken tablets due to teratogenic potential; hazardous substance
FLUoxetine	Weekly Capsule: Delayed release
fluvastatin	Tablet Extended release
fluvoxaMINE	Capsule Slow release
gabapentin	Tablet Extended release Capsule: ISMP recommendation
galantamine	Capsule Extended release
ganciclovir	Tablet Irritant potential; teratogenic potential; hazardous substance
glipiZIDE	Tablet Extended release
guaiFENesin	Tablet Slow Release
guaifenesin-pseudoephedrine	Tablet Slow release
guanFACINE	Tablet Extended release
HYDROmorphone	Tablet Extended release; breaking, chewing, crushing, or dissolving before ingestion or injecting increases the risk of overdose Capsule Extended release Tablet Extended release
hydroxyurea	Capsule Manufacturer recommendation; hazardous substance Tablet Manufacturer recommendation; hazardous substance
hyoscyamine	Tablet Extended release Tablet Controlled release
ibandronate	Tablet Irritant. Chewed, crushed, or sucked tablets may cause oropharyngeal irritation.
ibuprofen	DO NOT CRUSH for oral administration. Can crush for administration via tube.
imatinib	Tablet Manufacturer recommendation; mucous membrane irritant; hazardous substance
indinavir	Capsule Taste. Capsule may be opened and mixed with fruit puree (eg, banana)
indomethacin	Capsule Extended release
isosorbide dinitrate	Tablet Extended release Tablet Sublingual form
isosorbide mononitrate	Tablet Extended release
lamoTRIgine	Tablet Extended release
lansoprazole	Capsule Delayed release Suspension Slow release. Contains enteric-coated granules. Not for use in NG tubes; mix with water only Tablet Orally disintegrating. Do not swallow; dissolve in water only and dispense via dosing syringe or NG tube.
levETIRAcetam	Tablet Extended release Tablet Taste
lithium	Tablet Extended release
lopinavir-ritonavir	Tablet Film-coated; pharmacokinetic amorphous solid dispersion technology may be affected; pregnant women or women who may become pregnant should not handle crushed or broken tablets; active ingredients surrounded by wax matrix to prevent health care
loratadine	Tablet Extended release
loratadine-pseudoephedrine	Tablet Extended release
lovastatin	Tablet Extended release
memantine	Capsule Extended release
mesalamine	Capsule/Tablet Extended release Capsule/Tablet Slow release Tablet Delayed release, enteric-coated
metFORMIN	Tablet Extended release
metformin-sitagliptin	Tablet Extended release
methylphenidate	Capsule Extended release/Slow release: Capsule may be opened, sprinkled onto a tablespoon of applesauce or yogurt, and consumed without chewing within 10 minutes Capsule Controlled release Orally disintegrating tablet Extended release; orally disintegrating tablet designed to disintegrate on the tongue
metoprolol	Capsule Extended release Tablet Extended release
minocycline	Tablet Extended release Capsule Mucous membrane irritant; slow release Capsule Extended release
mirabegron	Tablet Extended release
morphine	Tablet Slow release; tablet disruption may cause a potentially fatal overdose. Capsule Extended release . Do not give via NG tubes; may add contents to applesauce without crushing. Capsule disruption may cause a potentially fatal overdose Tablet Extended release ; tablet disruption may cause a potentially fatal overdose
mycophenolate mofetil	Capsule, tablet Teratogenic potential; hazardous substance
mycophenolic acid	Tablet Delayed release; enteric-coated; teratogenic potential; hazardous substance
naproxen	Tablet Delayed release; enteric-coated Tablet Extended release
nevirapine	Tablet Extended release
niacin	Capsule/Tablet Extended release Tablet Slow release
NIFEdipine	Tablet Extended release Capsule Pharmacokinetics may be altered if not taken whole
nitroglycerin	Tablet Sublingual route
omega-3 polyunsaturated fatty acids	Capsule Contents of capsule may erode walls of styrofoam or plastic materials
omeprazole	Capsule Delayed release Tablet Delayed release
orphenadrine	Tablet Extended release
oxybutynin	Tablet Extended release
oxyCODONE	Tablet Not amenable to crushing; may obstruct feeding tubes Tablet Extended release; surrounded by wax matrix; tablet disruption may cause a potentially fatal overdose
oxyMORphone	Tablet Extended release; tablet disruption may cause a potentially fatal overdose
paliperidone	Tablet Extended release
pancrelipase	Capsule Delayed release; enteric-coated contents Tablet Mucous membrane irritant
pantoprazole	Tablet Slow release
PARoxetine	Tablet Extended release Tablet Film-coated
pentoxifylline	Tablet Extended release
piroxicam	Capsule Mucous membrane irritant
posaconazole	Tablet Delayed release; pharmacokinetic amorphous solid dispersion technology may be affected. Administration of crushed delayed release tablets via an enteral feeding tube has been described; refer to drug monograph for detailed recommendations.
potassium bicarbonate-potassium citrate	Tablet Effervescent tablet
potassium chloride	Tablet Slow release Tablet Extended release Capsule Extended release
potassium citrate	Tablet Wax-coated; prevents upper GI release
pramipexole	Tablet Extended release
prednisoLONE	Tablet Orally disintegrating. Do not break, cut, split, or use partial tablet; may swallow whole or allow tablet to dissolve on tongue.
predniSONE	Tablet Delayed release; release is dependent upon intact coating
propafenone	Capsule Extended release
propranoloL	Capsule Extended release
pseudoephedrine	Capsule Extended release
pyridostigmine	Tablet Extended release
QUEtiapine	Tablet Extended release
raloxifene	Tablet Taste; teratogenic potential; hazardous substance
ranolazine	Tablet Slow release
risedronate	Tablet Irritant. Chewed, crushed, or sucked tablets may cause oropharyngeal irritation Tablet Extended release; tablet coating is an important part of the delayed release
ritonavir	Tablet Manufacturer recommendation; crushing tablets has resulted in decreased bioavailability of drug; pharmacokinetic amorphous solid dispersion technology may be affected
rOPINIRole	Tablet Extended release
sevelamer	Tablet Manufacturer recommendation; expands in liquid if broken or crushed.
sirolimus	Tablet Manufacturer recommendation; hazardous substance; pharmacokinetic Nano-Crystal technology may be affected.
sulfaSALAzine	Tablet Delayed release
tamsulosin	Capsule Slow release; manufacturer recommendation. Capsules may be opened and contents mixed with food (eg, yogurt or pudding) or juice; refer to drug monograph for detailed recommendations
tapentadol	Tablet Extended release; tablet disruption may cause a potentially fatal overdose
temozolomide	Capsule Manufacturer recommendation; hazardous substance. Note: If capsules are accidentally opened or damaged, rigorous precautions should be taken to avoid inhalation or contact of contents with the skin or mucous membranes.
theophylline	Capsule Extended release; contains beads that dissolve through GI tract Tablet Extended release Tablet Slow release
tolterodine	Capsule Extended release
topiramate	Capsule Extended release Capsule/Tablet: Taste
traMADol	Capsule Variable release; tablet disruption may cause overdose Tablet Extended release; Tablet disruption my cause a potentially fatal overdose.
traZODone	Tablet Extended release
valGANciclovir	Tablet Irritant potential ; teratogenic potential; hazardous substance
valproic acid	Capsule Slow release; mucous membrane irritant; hazardous substance
venlafaxine	Capsule Extended release Tablet Extended release
verapamil	Tablet Extended release; pharmacokinetic amorphous solid dispersion technology may be affected Capsule Sustained/Extended release
zolpidem	Tablet Extended release Tablet Sublingual form

This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.